427 related articles for article (PubMed ID: 17341540)
1. Lercanidipine in the treatment of hypertension.
Beckey C; Lundy A; Lutfi N
Ann Pharmacother; 2007 Mar; 41(3):465-73. PubMed ID: 17341540
[TBL] [Abstract][Full Text] [Related]
2. Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers.
Makarounas-Kirchmann K; Glover-Koudounas S; Ferrari P
Clin Ther; 2009 Aug; 31(8):1652-63. PubMed ID: 19808126
[TBL] [Abstract][Full Text] [Related]
3. Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study.
Barrios V; Escobar C; de la Figuera M; Llisterri JL; Honorato J; Segura J; Calderón A
Cardiovasc Ther; 2008; 26(1):2-9. PubMed ID: 18466416
[TBL] [Abstract][Full Text] [Related]
4. A randomised, double-blind, double-dummy comparison of the efficacy and tolerability of lercanidipine tablets and losartan tablets in patients with mild to moderate essential hypertension.
James IG; Jones A; Davies P
J Hum Hypertens; 2002 Aug; 16(8):605-10. PubMed ID: 12149668
[TBL] [Abstract][Full Text] [Related]
5. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
6. Hypertension, possible vascular protection and lercanidipine.
Ram CV
Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):783-8. PubMed ID: 17173495
[TBL] [Abstract][Full Text] [Related]
7. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
Burnier M; Pruijm M; Wuerzner G
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
[TBL] [Abstract][Full Text] [Related]
8. Lercanidipine in hypertension.
Borghi C
Vasc Health Risk Manag; 2005; 1(3):173-82. PubMed ID: 17319103
[TBL] [Abstract][Full Text] [Related]
9. Lercanidipine : a review of its efficacy in the management of hypertension.
Bang LM; Chapman TM; Goa KL
Drugs; 2003; 63(22):2449-72. PubMed ID: 14609358
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive effects of lercanidipine in experimental hypertensive rats and dogs.
Sironi G; Montagna E; Greto L; Bianchi G; Leonardi A; Testa R
Arzneimittelforschung; 1996 Feb; 46(2):145-52. PubMed ID: 8720303
[TBL] [Abstract][Full Text] [Related]
11. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
12. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
13. Lercanidipine vs lacidipine in isolated systolic hypertension.
Millar-Craig M; Shaffu B; Greenough A; Mitchell L; McDonald C
J Hum Hypertens; 2003 Nov; 17(11):799-806. PubMed ID: 14578921
[TBL] [Abstract][Full Text] [Related]
14. Clevidipine: an ultra short-acting calcium channel antagonist for acute hypertension.
Kenyon KW
Ann Pharmacother; 2009 Jul; 43(7):1258-65. PubMed ID: 19584385
[TBL] [Abstract][Full Text] [Related]
15. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
[TBL] [Abstract][Full Text] [Related]
16. Comparative effect of lercanidipine, felodipine, and nifedipine GITS on blood pressure and heart rate in patients with mild to moderate arterial hypertension: the Lercanidipine in Adults (LEAD) Study.
Romito R; Pansini MI; Perticone F; Antonelli G; Pitzalis M; Rizzon P
J Clin Hypertens (Greenwich); 2003; 5(4):249-53. PubMed ID: 12939564
[TBL] [Abstract][Full Text] [Related]
17. [Lercanidipine, a third generation calcium antagonist. Which advantages?].
Meier P; Burnier M
Rev Med Suisse; 2006 Sep; 2(78):2047-50, 2052-3. PubMed ID: 17019840
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of lercanidipine in the general practice setting].
Robles NR; Canelada JA; Iglesias M; Angulo E; López Acedo A; Díaz Olea E; Cidoncha F; Guerras M; Fuentes J; Garrido J; Lapie J; Peña J; Aguilar A; Hidalgo P
An Med Interna; 2003 Jun; 20(6):282-6. PubMed ID: 12848597
[TBL] [Abstract][Full Text] [Related]
19. Clevidipine for the treatment of severe hypertension in adults.
Nguyen HM; Ma K; Pham DQ
Clin Ther; 2010 Jan; 32(1):11-23. PubMed ID: 20171407
[TBL] [Abstract][Full Text] [Related]
20. Improved tolerability of the dihydropyridine calcium-channel antagonist lercanidipine: the lercanidipine challenge trial.
Borghi C; Prandin MG; Dormi A; Ambrosioni E;
Blood Press Suppl; 2003 May; 1():14-21. PubMed ID: 12800983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
